Phase 2 Study of DKN-01 in Colorectal Cancer

NCT05480306 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Colorectal Adenocarcinoma
Colo-rectal Cancer
Colorectal Cancer Metastatic

Interventions

DRUG: DKN-01
DRUG: FOLFIRI
DRUG: Bevacizumab
DRUG: FOLFOX

Sponsor

Leap Therapeutics, Inc.